Advancing a clinical drug targeting the complement system to treat COVID-19 (2021–2022)

COVID-19 is an infectious and potentially lethal respiratory disease that has altered the way we all live. There is, therefore, an urgent need to identify effective drugs for this disease. This project entails validating and advancing a pre-existing clinical drug that targets our immune system, in the hope of finding an effective therapy for COVID-19 patients.
Grant type:
Advance Queensland Industry Research Fellowships
  • Senior Research Fellow
    School of Biomedical Sciences
    Faculty of Medicine
Funded by:
Queensland Government Department of Innovation, Tourism Industry Development